Senior Scientist, Quantitative Pharmacology and Pharmacometrics

We are looking for a highly-motivated Senior Scientist with a passion for Quantitative Pharmacology and Pharmacometrics to join our team at Merck & Co. As a member of our team, you will play a vital role in our multi-disciplinary research and development efforts by leveraging your expertise in mathematical modeling and statistical analysis to understand drug-disease interactions and to inform decision-making in clinical development.To be successful in this role, you will need to possess a Ph.D. in a quantitative discipline such as Pharmacology, Pharmacometrics, Pharmacokinetics, Biostatistics, or a related field. You must also have a proven track record of leading and executing projects and should be comfortable working with various stakeholders across research, development, and medical teams. Your excellent communication and collaboration skills, as well as your ability to think strategically and solve complex problems, will be key to your success in this role. We are excited to welcome you to our team and look forward to seeing the contributions you will make in advancing the development of medicines that can improve the lives of patients around the world.

According to JobzMall, the average salary range for a Senior Scientist, Quantitative Pharmacology and Pharmacometrics in Rahway, NJ 07065, USA is $105,000 - $145,000 per year. This range may vary depending on the experience and qualifications of the individual.

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company and one of the largest pharmaceutical companies in the world. Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Alliances and Healthcare Services. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures.